FIELD: chemistry.
SUBSTANCE: pyrazole derivatives are disclosed, which are encompassed by formula (I), in which radicals and groups are defined in patent claim and which are suitable for treating disorders mediated by peripheral cannabinoid 1 receptor 1.
EFFECT: invention also discloses pharmaceutical compositions and methods related to use of said compounds.
29 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
NOVEL 1,2-BIS-SULPHONAMIDE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR | 2011 |
|
RU2654213C9 |
1,3,5-TRISUBSTITUTED DERIVATIVES OF 4,5-DIHYDRO-1H-PYRAZOLE, POSSESSING CB-ANTAGONISTIC ACTIVITY | 2005 |
|
RU2360904C2 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
NOVEL COMPOUND OF 2,3,5-SUBSTITUTED THIOPHENE AS A PROTEIN KINASE INHIBITOR | 2017 |
|
RU2724957C2 |
DERIVATIVES OF 1H-IMIDAZOLE POSSESSING CB-AGONISTIC, PARTIAL CB-AGONISTIC OR CB-ANTAGONISTIC ACTIVITY | 2002 |
|
RU2299200C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
DERIVATIVES OF 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE EFFECTIVE AS CB1 MODULATORS | 2005 |
|
RU2375349C2 |
BENZENE OR THIOPHEN DERIVATIVE AND USING IT AS VAP-1 INHIBITOR | 2009 |
|
RU2526256C2 |
Authors
Dates
2016-10-27—Published
2012-09-25—Filed